After participating in this educational activity, attendees should be able to:
1. Explain the risk and typical treatment strategy for thrombotic events in patients antiphospholipid syndrome (APS)

2. Identify challenges in monitoring activated partial thromboplastin time (aPTT) in patients with APS.


    3. Discuss strategies for monitoring heparin antifactor Xa levels in patients receiving unfractionated heparin and its correlation to aPTT levels.



      Leah Mangini, PharmD
      PGY1 Pharmacy Resident


      Baystate Medical Center 

      None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

        Session date: 
        06/11/2018 - 2:00pm to 3:00pm EDT
        Baystate Medical Center
        759 Chestnut Street
        North Administration Conference Room
        Springfield, MA 01199
        United States
        • 1.00 ACPE Contact Hours

        Please login or register to take this course.